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Abstract: 
Stress influences the risk of cardiovascular disease. Acute mental stress can induce both low-
grade inflammation and endothelial dysfunction.  The relationship between inflammatory 
responses to stress and future endothelial function is unexplored. Knowledge on the impact of 
other cardiovascular risk factors, such as dyslipidaemia, on such relationships is also limited   
We investigated the relationship between inflammatory responses to an acute mental stress 
challenge and endothelial function plus the influence of dyslipidaemia on the associations.  
Interleukin-6 (IL-6), tumor necrosis factor α (TNFα) and fibrinogen were assessed at 
baseline, immediately following standardized behavioural tasks and 45 minutes post-task in 
158 participants.  Blood pressure and heart rate responses were measured. Flow-mediated 
dilatation (FMD) was measured 3 years later.  Fibrinogen and IL-6 increased post-stress 
(p=<0.001 &0.003) but TNFα was unchanged (p=0.09).  An independent negative association 
between FMD and change in fibrinogen at 45 minutes (β=-0.047 p=0.016) remained after 
multiple adjustment (baseline fibrinogen, baseline diameter, reactive hyperaemia, age, gender 
and other cardiovascular risk factors).  There was no association between FMD and change in 
IL-6 or TNFα. There were no differences in the responses to stress between those with and 
without dyslipidaemia. However, there was an interaction between the presence of 
dyslipidaemia and immediate change in fibrinogen with stress which was associated with 
FMD.  Those participants with dyslipidaemia who had a greater change in fibrinogen had 
lower FMD. We conclude that elevated fibrinogen responses to stress are associated with 
future endothelial dysfunction which may reflect increased cardiovascular risk. 
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1. Introduction: 
There is substantial evidence for an association between psychosocial stress and the 
development of cardiovascular disease, which has led to it being considered as an important 
cardiovascular risk factor (Everson-Rose and Lewis, 2005; Steptoe and Kivimaki, 2013; 
Yusuf et al., 2004). However, despite recent advances, the pathophysiological pathways 
connecting the two are not yet fully understood. Assessment of the dynamic cardiovascular 
and inflammatory responses to acute mental stress challenges provides the opportunity to 
understand more fully the potential mechanisms by which everyday psychological stresses 
influence the development of cardiovascular pathophysiology. In turn this may improve our 
understanding of how stress influences the presentation of clinical disease and may offer 
potential novel targets for treatment.   
Inflammation plays a key role in the initiation, development and destabilisation of 
atherosclerotic plaques (Hansson et al., 2015). Low grade systemic inflammation is 
associated with adverse cardiovascular risk in those with and without cardiovascular disease 
(Liuzzo et al., 1994; Ridker et al., 1997). Acute stressors trigger inflammatory responses 
which may play a role in the pathogenesis of cardiovascular disease (Steptoe and Brydon, 
2009; Steptoe et al., 2007). 
Endothelial vasomotor function is a well-established measure of general vascular health. 
Flow-mediated dilatation (FMD), a non-invasive measure of endothelial function, is 
diminished in the presence of traditional cardiovascular risk factors and also in the setting of 
inflammatory conditions (Celermajer et al., 1994; Celermajer et al., 1992; Di Minno et al., 
2015; Woo et al., 2004). Furthermore, both acute inflammation, for example post vaccination, 
and acute mental stress have been shown to cause transient impairment of endothelium 
dependent dilatation in otherwise healthy people (Ghiadoni et al., 2000; Hingorani et al., 
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2000; Spieker et al., 2002).  This may be due to the effects of inflammatory cytokines and 
fibrinogen which activate the endothelium, reducing nitric oxide bioavailability (Hansson et 
al., 2015; Tousoulis et al., 2011). We have also previously shown that those with the most 
pronounced inflammatory responses (interleukin-6 [IL-6], tumor necrosis factor α [TNFα] 
and fibrinogen)  to acute mental stress had greater arterial stiffness and increases in 
ambulatory systolic blood pressure when assessed three years later (Brydon and Steptoe, 
2005; Ellins et al., 2008). Therefore the inflammatory response to acute mental stress 
characterised in this way could serve as an individual biomarker of risk for the development 
of endothelial dysfunction and subsequent cardiovascular events. 
Dyslipidaemia is associated with increased cardiovascular risk and endothelial dysfunction as 
well as a raised inflammatory profile (Andersson et al., 2014; Celermajer et al., 1992; Ueland 
et al., 2006).  There is limited work looking at how responses to acute stress might be further 
influenced by the presence of cardiovascular risk factors such as dyslipidaemia.  One small 
study in men with mixed dyslipidaemia saw no difference in the haemodynamic responses to 
acute stress challenges compared to controls with normal lipids (McCann et al., 1995).  
However, subjects with type II diabetes have been shown to have blunted blood pressure, 
heart rate and IL-6 responses to an acute mental stress (Steptoe et al., 2014). Studies looking 
at the effect of the presence of risk factors on the endothelial response to stress are also few in 
number and small in size, with mixed findings. They also do not look at how responses to 
stress might influence endothelial function over the longer term (Cardillo et al., 1998; 
Ghiadoni et al., 2000) . We have previously shown that greater Fibrinogen and TNFα 
responses following a modest acute pyschophysiological stress stimulus was associated with 
increased carotid arterial stiffness, a measure of structural arteriosclerotic/atherosclerotic 
changes, in middle aged civil servants. The relationships between inflammatory responses to 
acute mental stress and future endothelial function, a more dynamic measure of arterial 
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(patho)physiology than arterial stiffness and the potential influence of dyslipidaemia have not 
been investigated. The aim of this study was (a) to investigate associations between 
inflammatory responses to acute mental stress and endothelial function assessed at three 
years, and (b) to evaluate the potential influence of an adverse lipid profile on this 
association. 
2. Materials and Methods: 
2.1. Participants 
The Whitehall II epidemiological cohort consisted of 10,308 nonindustrial civil servants aged 
35 to 55, who were recruited between 1985 and 1988 to investigate social and occupational 
influences on health and disease.  Follow-up of these participants has occurred through clinic 
visits and self-administered questionnaires every 2-5 years. Between 1999 and 2000, 123 men 
and 105 women from the Whitehall II Study underwent psychophysiological testing as part of 
a psychobiology sub-study (Marmot et al., 1991; Steptoe et al., 2002a).  Participants within 
the sub-study were of white European origin, aged 45-59 years, lived in London, and were in 
full time work, with no history or indicators for coronary heart disease or hypertension. 
Selection had been stratified by employment grade to ensure a wide range of socio-economic 
status.  158 participants (52±3 years) underwent endothelial function assessment during 
Phase 7 of the cohort study, 3 years after psychophysiological stress testing.  
2.2 Psychophysiological stress testing 
Studies took place in the morning or afternoon in a temperature-controlled laboratory. 
Participants were asked to refrain from drinking alcohol or exercising on the evening before 
or the day of testing, and to not drink caffeine or smoke for 2 hours prior to the study. Blood 
pressure and heart rate were continuously monitored during the study using a Partapress-2 
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(Finapress Medical Systems, Amsterdam, NL).  Participants rested for 30 minutes following 
the insertion of a cannula for blood sample collection.  During the last 5 minutes of the rest 
period, baseline blood pressure and heart rate were recorded and a baseline blood sample was 
drawn. Following this, two moderately stressful tasks were administered in a random order 
with a 5 minute inter-task interval. These tasks (computerized colour-word interference task 
and mirror tracing) have previously been used in cardiovascular stress research (Jennings et 
al., 2004). The rationale for using these tasks is explained elsewhere (Steptoe and Marmot, 
2002). 
The two tasks each lasted 5 minutes. A second blood sample was taken immediately post the 
second task and participants were left to rest quietly, reading or watching wildlife videos. 
Two 5 minute post-stress blood pressure and heart rate recordings were made at 15-20 
minutes and 40-45 minutes. A final blood sample was taken after 45 minutes. The study was 
approved by the UCL/UCLH Committee on the Ethics of Human Research. 
2.3 Blood assays 
Blood samples were collected in EDTA tubes and serum gel tubes, and centrifuged 
immediately at 2500 rpm for 10 min at room temperature. The plasma was removed and 
stored at -80 
o
C until analysis. We have shown in previous studies that fibrinogen responds 
immediately to psychological stress, while increases in IL-6 and TNFα emerge after 30–45 
min (Steptoe et al., 2007; Steptoe et al., 2003). Fibrinogen was therefore assayed from all 
three samples, whilst IL-6 and TNFα were only assessed from the baseline and 45 min post-
stress samples. C-reactive protein (CRP) was measured from baseline samples only. Clottable 
fibrinogen was measured by an automated Clauss assay in a MDA-180 coagulometer 
(Oragon Teknika, Cambridge, UK). The coefficient of variation (CV) was <8%. IL-6 and 
TNFα were measured using high sensitivity two-site ELISAs from R&D Systems (Oxford, 
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UK). The limit of detection of the human TNFα assay was 0.10 pg/ml and intra- and inter-
assay CVs were 6.9% and 8.4%. For IL-6, the limit of detection was 0.09 pg/ml, and intra- 
and inter-assay CVs were 5.3% and 9.2%. CRP was detected using a sensitive, two-site 
ELISA with antibodies from Dako diagnostics (Ely, Cambs, UK). The inter- and intra-assay 
CVs were 2.5% and 4.1%. 
 
The serum was snap frozen at -70
o
C until analysis. Samples were taken at baseline only. 
Total cholesterol and triglycerides were measured in a centrifugal analyser by enzymatic 
colorimetric methods and HDL cholesterol was determined after dextran sulphate-magnesium 
chloride precipitation of non-HDL cholesterol.  LDL was computed using the Friedewald 
equation.  
 
2.4 Other measures 
Height, weight, waist and hip circumference were assessed and used to calculate body mass 
index (BMI) and waist/hip ratio.  Socio-economic status (SES) based on current or last 
known grade of employment was determined by questionnaire as was smoking status. 
2.5 Endothelial function assessment 
Flow-mediated dilatation was assessed in the right brachial artery using high resolution 
ultrasound (Prosound 5500 ALOKA) as previously described (Donald et al., 2006). Analysis 
of changes in brachial artery diameter was done using automated edge detection software 
(Brachial Tools, Iowa City, Iowa). FMD was expressed as absolute change in diameter from 
baseline.  Reactive hyperaemia was calculated from the baseline and maximal velocity time 
integral in the first 15 seconds following cuff release and expressed as a percentage.  
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2.6 Statistical analysis 
SPSS version 20 was used for the analyses. Data were checked for normality and those non-
normally distributed variables were transformed using ln transformation.  Five participants 
were excluded from the analysis as they had starting taking lipid or blood pressure 
medication since undergoing stress testing. Differences between baseline characteristics 
between males and females were tested using independent samples t-tests or the independent 
samples Mann Whitney U test. Chi square was used to assess for differences between 
smoking and SES status.  Relationships between FMD and conventional risk factors were 
assessed using partial correlations adjusted for age, gender, baseline diameter and reactive 
hyperaemia. Haemodynamic and inflammatory responses to psychological stress testing were 
assessed using repeated measures analysis of variance with trial as the within-subject factor.  
Post-hoc comparisons were made using Tukey’s least significant differences (LSD) test. 
Gender was then added to the model as a between subject-factor to investigate whether there 
were differences in the stress responses between the two groups. 
Presence of associations between endothelial function and inflammatory responses were 
investigated using multiple linear regression. Adjustments were made for baseline 
inflammatory variable, baseline brachial artery diameter, reactive hyperaemia, age, gender, 
BMI, waist/hip ratio, systolic and diastolic blood pressure, HDL and LDL cholesterol, 
glucose, socioeconomic status and smoking. 
2.6.1 Dyslipidaemia 
Participants were classified as having dyslipidaemia if they met one of the following criteria. 
Total cholesterol ≥ 6 triglycerides ≥ 1.7 HDL <1 LDL≥4 (mmol/L). Comparisons were made 
between those with and without dyslipidaemia using independent t-tests. Repeated measures 
ANOVAs were used including dyslipidaemia as a between subject-factor to investigate 
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whether dyslipidaemia influenced the responses to stress. To investigate whether the presence 
of dyslipidaemia and the inflammatory response influenced future endothelial function the 
effect of interactions between dyslipidaemia and change in each inflammatory variable in 
response to stress on FMD were tested using linear regression. Baseline diameter, reactive 
hyperaemia and baseline inflammatory variable were also included in the analysis.  
3. Results: 
3.1 Participant characteristics 
Characteristic All (n=153) Male (n=84) Female (n=69) p 
Age (yrs) 52 ± 3 53 ± 3 52 ± 3 0.021 
Smoker (Y) 9 (5.9%) 6 (7.1%) 3 (4.2%) 0.47 
SES     
Higher 60 (39.2%) 34 (40.5%) 26 (37.7%) 0.84 
Intermediate 50 (32.7%) 28 (33.3%) 22 (31.9%)  
Lower 43 (28.1%) 22 (26.2%) 21 (30.4%)  
BMI (kg/m2) 25.23 ± 3.52 25.36 ± 3.25 25.08 ± 3.85 0.63 
Waist/hip ratio 0.84 ± 0.09 0.90 ± 0.07 0.78 ±0.06 <0.001 
SBP(mmHg) 114 ± 12 118 ± 11 109 ± 12 <0.001 
DBP(mmHg) 69 ± 9 71 ± 9 67 ± 9 0.005 
HR(bpm) 64  ± 8 64 ± 9 66 ± 8 0.14 
TC(mmol/L) 5.38 ± 0.87 5.42 ± 0.84 5.32 ± 0.91 0.47 
Trigs (mmol/L)  1.34 ± 0.71 1.45 ± 0.65 1.21 ± 0.76 0.003 
HDL (mmol/L) 1.57 ± 0.39 1.43 ± 0.30 1.74 ± 0.41 <0.001 
LDL (mmol/L)  3.20 ± 0.81 3.34 ± 0.79 3.02 ± 0.82 0.018 
Total/HDL 3.65 ± 1.13 3.96 ± 1.01 3.24 ± 1.13 <0.001 
Glucose (mmol/L) 5.30 ± 0.79 5.34 ± 0.72 5.25 ± 0.88 0.54 
CRP (mg/L) 1.02 ± 1.29 0.92 ± 0.97 1.13 ± 1.59 0.8 
BL dia (mm)* 3.60 ± 0.71  4.02 ± 0.61 3.08 ± 0.41 <0.001 
FMD (mm)* 0.19 ± 0.10 0.19 ± 0.10 0.20 ± 0.10 0.81 
RH% (%)* 658 ± 260 648 ± 249 665 ± 270 0.61 
Table 1: Participant characteristics for all and by gender. SES= socio-economic status; BMI= body mass index; 
SBP = systolic blood pressure; DBP= diastolic blood pressure; HR=heart rate; TC=total cholesterol; 
Trigs=triglycerides; HDL=high density lipoprotein; LDL=low density lipoprotein; CRP= C-reactive protein; BL 
dia= brachial artery baseline diameter; FMD=flow-mediated dilatation; RH%= Reactive hyperaemia as a 
percentage. *Assessed at phase 7. 
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Table 1 shows the characteristics for those participants included in the study.  Males were 
older with a greater waist/hip ratio, blood pressure, triglycerides, LDL, Total/HDL ratio and 
brachial artery diameter, whilst HDL was significantly lower (p<0.03).  
3.2 Associations with conventional risk factors 
FMD was correlated with diastolic blood pressure (DBP) and heart rate (HR) following 
adjustment for age, gender, baseline diameter and reactive hyperaemia (DBP r= 0.18 p=0.037 
& HR r=0.23 p =0.007).  No other conventional risk factors, including systolic blood 
pressure, BMI, waist/hip ratio, total cholesterol, LDL, HDL, triglycerides, glucose and CRP,  
were associated with FMD. In addition there were no significant correlations between FMD 
and baseline IL-6, TNFα or fibrinogen. 
3.3 Responses to acute mental stress 
Systolic- and diastolic-BP and HR all increased in response to the mental stress challenge (all 
p<0.001). Both fibrinogen and IL-6 increased post-stress (p <0.001 & 0.003 respectively). 
The increase in TNFα levels post stress did not reach significance (p= 0.09) (Table 2).  There 
were no differences in the responses by gender except for TNFα (F(1,140) 4.0 p=0.047).  
This was due to an increase in TNFα in men (baseline 2.19 pg/ml vs post-stress 2.31 pg/ml) 
and a decrease in women (baseline 2.04 pg/ml vs post-stress 2.02 pg/ml). 
  Baseline Stress tasks  Recovery 1 Recovery 2 F p 
SBP (mmHg) 114 138
*
 119
*≠
 119
*≠
 250.3 <0.001 
DBP (mmHg) 69 83
*
 73
*≠
 74
*≠
 268.3 <0.001 
HR (bpm) 65 72
*
 62
*≠
 63
*≠°
 234.7 <0.001 
Fbg (g/L) 2.81 2.87
*
  2.85
*
 13.4 <0.001 
IL-6 (pg/ml) 1.12   1.20
*
 9.2 0.003 
TNFα (pg/ml) 2.12     2.18 2.9 0.09 
Table 2: Haemodynamic and inflammatory responses to a psychophysiological challenge. Geometric means 
shown for IL-6 and TNFα and arithmetic means for all other measures. Values that have different superscripts 
are significantly different 
*
= from baseline, 
≠
=from task, 
O
=from recovery1 (p<0.05) SBP = systolic blood 
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pressure; DBP= diastolic blood pressure; HR=heart rate; Fbg=fibrinogen; IL-6=interleukin-6; TNFα= tumor 
necrosis factor α.   
3.4 Change in inflammatory markers and association with future endothelial function 
 
Figure 1: FMD (natural log) by high and low fibrinogen (fbg) response 45 minutes after an acute mental stress 
challenge, adjusted for baseline arterial diameter, baseline fibrinogen and reactive hyperaemia. Data are mean ± 
standard error. 
To investigate the influence of the haemodynamic and inflammatory responses to an acute 
mental stress challenge on future endothelial function multiple linear regression modelling 
between FMD and haemodynamic and inflammatory variables was used. Changes in heart 
rate and blood pressure post-stress were not associated with endothelial function (data not 
shown). However, there was a significant negative association between FMD and elevated 
fibrinogen at 45 minutes after adjustment for baseline arterial diameter and reactive 
hyperaemia (β= -0.038 [0.018] p= 0.041). The relationship remained after adjustment for 
baseline fibrinogen, age and gender (β= -0.037 [0.018] p= 0.048), and after the addition of 
cardiovascular risk factors , waist/hip ratio, BMI , SBP, DBP, glucose, HDL and LDL (β= -
0.046 [0.019] p= 0.017). This association was still present after the addition of socio-
0
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p=0.006 
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economic status and smoking status to the model (β= -0.047 [0.019] p= 0.016), indicating 
that those participants with a greater change in fibrinogen at 45 minutes had lower FMD 3 
years later.  There were no relationships between FMD and the other inflammatory measures. 
3.5 Dyslipidaemia, inflammatory responses to acute mental stress and endothelial function 
62 (21 females) participants met the criteria for dyslipidaemia, with the majority of 
participants having only one abnormal lipid variable (see supplemental table 1). Those with 
dyslipidaemia were more likely to be male (p=0.025) and to have greater BMI, waist hip ratio 
and CRP levels (p<0.001). There was no difference in FMD between those with and without 
dyslipidaemia (p=0.75). 
There were no differences in haemodynamic and inflammatory responses to the 
psychophysiological stress challenge between the two groups (p>0.05). 
There were no significant interactions between dyslipidaemia and inflammatory responses to 
stress for FMD for the majority of the variables (data not shown) except change in fibrinogen 
immediately after stress (β=-0.080 [0.019] p=0.024).  Further exploration identified that in 
those with dyslipidaemia a greater change in fibrinogen was associated with lower FMD (β=-
0.053 [0.022] p=0.018).  There was no association between the immediate fibrinogen 
response to stress and FMD in those with normal lipids (β=0.000 [0.015] p=0.99).   
 
4. Discussion: 
The main finding of this study is that those participants who had a higher fibrinogen response 
to a psychophysiological stress challenge had less well preserved endothelial function when 
assessed 3 years later following adjustment for key relevant cardiovascular risk factors.  This 
complements our previous analyses in this cohort which found increased arterial stiffness and 
15 
 
ambulatory blood pressure in those participants who had increased inflammatory responses to 
a stress challenge (Brydon and Steptoe, 2005; Ellins et al., 2008). 
Endothelial dysfunction is an early indicator of atherogenesis. This can be assessed by FMD 
which provides a measure of change in vasomotor tone caused by the local release of nitric 
oxide (NO) stimulated by the increase in shear stress during a standardised post-ischaemic 
hyperaemic response.  A poor FMD has been associated with numerous cardiovascular risk 
factors and an increased risk of cardiovascular events (Celermajer et al., 1994; Celermajer et 
al., 1992; Clarkson et al., 1996; Green et al., 2011; Woo et al., 2004). Acute mental stress 
causes endothelial dysfunction both during a stress challenge and immediately afterwards but 
the mechanisms for this are not yet fully understood (Eriksson et al., 2007; Ghiadoni et al., 
2000). Inhibition of cortisol and the endothelin-A receptor have both prevented the 
impairment of FMD induced by mental stress suggesting potential roles for both of these 
factors (Broadley et al., 2005; Spieker et al., 2002). 
 Inflammation plays a major role in the initiation, development and progression of 
atherosclerosis and is associated with endothelial dysfunction (Hansson et al., 2015). 
Although acute inflammation and acute mental stress have been shown to cause acute 
endothelial dysfunction there is limited work investigating whether and to what extent the 
acute inflammatory response to mental stress is implicated in the associated endothelial 
dysfunction (Clapp et al., 2004; Hingorani et al., 2000). One study by Ghiadoni et al 
measured the inflammatory markers IL-6, IL-1 & TNFα at baseline and 60 mins post stress 
challenge but did not see a significant change in these markers or any relationship between 
cytokine levels and FMD or change in FMD (Ghiadoni et al., 2000). Therefore our study 
linking fibrinogen at 45 minutes to FMD after three years is the first study to show an 
association between an inflammatory response to acute mental stress and future endothelial 
function.  There were no relationships between FMD assessed 3 years later and any of the 
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inflammatory measures assessed prior to the mental stress challenge. This may be due to the 
relatively healthy nature of the cohort with a low prevalence of obesity and other 
cardiovascular risk factors which are commonly associated with low grade inflammation and 
endothelial dysfunction. 
Fibrinogen, an acute phase protein induced by IL-6 in the inflammatory pathway and a major 
component of the coagulation cascade, is associated with increased risk of coronary heart 
disease and stroke (Danesh et al., 2005).  It has been implicated in the development of 
vascular dysfunction and atherosclerosis through its effects on plaque composition, blood 
viscosity, endothelial and smooth muscle cell activation, platelet aggregation and activation, 
and immune cell recruitment (Lominadze et al., 2010; Tousoulis et al., 2011).  
Increased fibrinogen may affect endothelial function both by mechanical and biochemical 
processes. Elevated fibrinogen increases blood viscosity which raises shear stress and 
activates endothelial cells (Davies et al., 2003; Lominadze et al., 2010; Lowe et al., 1997). 
This stimulates expression and activation of adhesion molecules and integrins, resulting in 
the attraction and adhesion of monocytes to endothelial cells and the greater production of 
vasoconstricting agents which may further affect endothelial function and vascular tone 
(Languino et al., 1993; Lominadze et al., 2005; Suehiro et al., 1997). 
Vascular injury triggers the coagulation cascade which results in fibrinogen being converted 
to fibrin which in turn forms a thin monolayer covering the damaged area.  This layer attracts 
platelets which are also activated by fibrinogen causing further platelet aggregation, 
inflammatory responses and endothelial dysfunction. As the injury heals the platelets can also 
become part of the developing lesion/plaque (Badimon, 2014). Therefore elevated levels of 
fibrinogen through reactions to acute stressors could further exacerbate this process. The lack 
of association between IL-6 and future endothelial function may suggest that it is these 
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haemostatic/prothrombotic properties of fibrinogen that could be more important in this 
setting than its inflammatory properties.  
It was interesting that an independent association between FMD was only seen with change 
in fibrinogen at 45 minutes post stress testing and not with change in fibrinogen immediately 
after the stress tests. This may indicate that the duration of exposure to a raised fibrinogen 
may be more important, reflecting more sustained activation of its haemostatic/prothrombotic 
and proinflammatory affects adversely influencing endothelial function over the longer term.   
Further studies looking at the time course of the fibrinogen response with more frequent 
assessment of fibrinogen levels over a longer period would allow a more detailed 
investigation of this relationship, although such a study could pose practical and ethical 
challenges in humans. 
Gender did not appear to influence the responses to acute mental stress except for TNFα 
which only increased in men and reflects previous findings (Steptoe et al., 2002b), but TNFα 
stress responses were not associated with endothelial function. 
The presence of dyslipidaemia did not appear to have any influence on the haemodynamic or 
inflammatory responses to an acute mental stress challenge. Although a little surprising, the 
severity of dyslipidaemia was only mild.  However, when examining interactions between the 
presence of dyslipidaemia and inflammatory responses to stress and their effect on 
endothelial function, a significant interaction between dyslipidaemia and change in 
immediate fibrinogen at stress and FMD was found.  Further exploration of this association 
showed that those participants with dyslipidaemia and a high fibrinogen response to stress 
had lower FMD.  Dyslipidaemia has previously been shown to be associated with poorer 
endothelial function but the additional presence of high levels of fibrinogen with its 
haemostatic and prothrombtic effects, even for a short period of time, may exacerbate the 
18 
 
development of endothelial function in this group with mild dyslipidaemia. Considered 
together with our observation of an independent relationship between fibrinogen at 45 
minutes and FMD the evidence of an interaction between dyslipidaemia and immediate 
fibrinogen response highlights the potential importance of this effect of stress on vascular 
pathophysiology. Further studies exploring the influence of fibrinogen stress responses and 
vascular outcomes in selected populations with dyslipidaemia and other cardiovascular risk 
factors would be valuable.  
There are a number of limitations to this study. Endothelial function was not assessed at the 
time of stress testing so it is unknown whether those participants with poorer FMD 3 years 
later already had endothelial dysfunction at the point of stress testing.  The population were 
originally selected for being free of cardiovascular disease so the dyslipidaemia group mainly 
consists of those with mild lipid abnormalities. More adverse lipid profiles such as in familial 
hypercholesterolaemia may well give different findings.  Additionally, blood samples for the 
mental stress study were not taken in a fasted state as the study protocol did not state the need 
for a pre-specified prior fast.  Therefore, some participants may have been classified as 
dyslipidaemic due to elevated triglycerides which may have been within the normal range if 
the participant had fasted. However, the important association between non-fasting 
triglycerides (and also LDL) and cardiovascular outcomes is well recognised and suggests it 
is not inappropriate to select participants on the basis of non-fasting triglycerides 
(Nordestgaard and Varbo, 2014). In addition it may also more accurately reflect an 
individual’s usual waking status as they would rarely be in a fully fasted state.   It is also 
worth noting that although 36 participants had elevated triglycerides within this population, 
21 of these individuals would also have been classified as having dyslipidaemia due to their 
TC, LDL or HDL levels. 
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Studies were carried out in both morning and afternoon sessions. Although we cannot 
exclude an influence of circadian rhythm, including an adjustment in our analyses for the 
time of day did not alter the relationship between fibrinogen responses and FMD. 
Furthermore, inflammatory measures were not associated with the time of day in a previous 
analysis of this dataset (Steptoe et al., 2002b).  
Measures of plasma adrenaline and noradrenaline were not assessed as venous measures of 
these hormones can be unreliable indicators of general activation of the sympathetic nervous 
system. In addition the half life of catecholamines in plasma is 1-2 min, and venous 
concentrations in the forearm have been shown to be primarily due to local muscle activity 
(Hjemdahl, 1993).  In order to assess dynamic autonomic function more reliably would have 
required complex, invasive and costly techniques which were not included in this protocol.  
However, significant increases in both blood pressure and heart rate in response to the tasks 
were seen in this study, which alongside self-reported measures of perceived stress 
previously reported in this cohort (Steptoe and Marmot, 2002) indicated the stressful nature 
of these challenges.   
These data are from a post-hoc analysis of the Whitehall II psychobiology study and the 
results are consistent with previously published analyses from this study showing a 
relationship between fibrinogen stress responses and large artery stiffness, strengthening the 
implications of those findings. We are unaware of similar cohorts in which an attempt to 
replicate these findings could be made at present, but we believe our results should encourage 
further prospective research to investigate further these potentially important relationships 
between stress, traditional risk factors and cardiovascular disease.  
In conclusion participants with an elevated fibrinogen response at 45 minutes post-stress and 
those with dyslipidaemia who had a greater immediate fibrinogen response to stress had 
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impaired endothelial function 3 years later. These results implicate the fibrinogen response to 
stress as a pathway through which psychological factors may contribute to the development 
of cardiovascular disease. 
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Supplement 
  Dyslipidaemia categories N
o
 of categories met 
  TC≥6 Trigs ≥1.7 HDL <1 LDL ≥4  1 2 3 
Yes 40 36 2 33 27 21 14 
No 112 116 150 119    
Supplement table 1: Number of participants who met each category for dyslipidaemia and the 
number of participants who met one or more of the categories. TC=total cholesterol; 
Trigs=triglyceride; HDL=high density lipoprotein; LDL=low density lipoprotein.  
